What You Should Know: - Theranica, a leader in neuromodulation devices for migraine and other chronic pain conditions, announced today that Highmark Inc. has included its Nerivio Remote Electrical Neuromodulation (REN) wearable in its commercial coverage policy for the acute and preventive treatment of migraine. - Highmark's coverage decision is a pivotal moment for migraine sufferers within their network. This opens doors for individuals previously limited by traditional treatment options
Read More
Migraines
ObvioHealth Launches Decentralized Clinical Trial for Migraine Treatment Device
What You Should Know: - ObvioHealth and Mi-Helper, Inc. announce a partnership to conduct a decentralized clinical trial for a non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial will be fully remote, enabling data capture from home—where the device is intended to be used. - Mi-Helper has been developed to meet a massive unmet need for effective, targeted, and drug-free pain management of migraines, a condition which impacts 1 billion
Read More